Publication Name	World Journal of Cardiology
Manuscript ID	16696
Country	Switzerland

Received	2015-01-27 13:59
Peer-Review Started	2015-01-28 18:41
To Make the First Decision	2015-02-07 14:45
Return for Revision	2015-02-12 11:43
Revised	2015-03-06 06:09
Second Decision	2015-09-21 17:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-30 18:30
Articles in Press	2015-09-30 18:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-12 16:30
Publish the Manuscript Online	2015-11-03 08:25

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Allergy
Manuscript Type	Frontier
Article Title	Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease
Manuscript Source	Invited Manuscript
All Author List	Ariel Beresniak, Thibaut Caruba, Brigitte Sabatier, Yves Juillière, Olivier Dubourg and Nicolas Danchin
Funding Agency and Grant Number	Funding Agency Grant Number Sanofi-Aventis
Corresponding Author	Ariel Beresniak, MD, MPH, PhD, Data Mining International, Research and Development, Route de l’Aéroport, 29-31, CP221, CH-1215 Geneva, Switzerland. aberesniak@datamining-international.com
Key Words	Cost-effectiveness; Percutaneous coronary; Coronary artery disease; Drug eluting stent
Core Tip	The objective of this study is to develop a robust cost-effectiveness model comparing drug eluting stents (DES) vs bare metal stent (BMS) in patients suffering of stable coronary artery disease. DES appeared slightly more efficacious over 2 years (60% of success) when compared to BMS (58% of success). Mean cost-effectiveness ratios showed slightly lower costs per success for the BMS strategy (15520€/success), as compared to the DES strategy (15588€/success). The sequential strategy including BMS as the first option appears to be less efficacious but more cost-effective compared to the strategy including DES as first option.
Publish Date	2015-11-03 08:25
Citation	Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol 2015; 7(10): 594-602
URL	http://www.wjgnet.com/1949-8462/full/v7/i10/594.htm
DOI	http://dx.doi.org/10.4330/wjc.v7.i10.594

Full Article (PDF)	WJC-7-594.pdf
Full Article (Word)	WJC-7-594.doc
Manuscript File	16696-Review.docx
Answering Reviewers	16696-Answering reviewers.pdf
Audio Core Tip	16696-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	16696-Conflict-of-interest statement.pdf
Copyright License Agreement	16696-Copyright assignment.pdf
Peer-review Report	16696-Peer-review(s).pdf
Scientific Misconduct Check	16696-Scientific misconduct check.pdf
Scientific Editor Work List	16696-Scientific editor work list.pdf